| Literature DB >> 35736454 |
Yuanyuan Liu1, Meijie Xu1, Yuqi Tang1, Yilan Shao1, Hong Wang1, Huawei Zhang1.
Abstract
Endophytic fungi are one of the most prolific sources of functional biomolecules with therapeutic potential. Besides playing an important role in serious plant diseases, Fusarium strains possess the powerful capability to produce a diverse array of bioactive secondary metabolites (SMs). In order to in-depth mine gene clusters for SM biosynthesis of the genus Fusarium, an endophytic strain Fusarium sp. R1 isolated from Rumex madaio Makino was extensively investigated by whole-genome sequencing and in-depth bioinformatic analysis, as well as antiSMASH annotation. The results displayed that strain R1 harbors a total of 51.8 Mb genome, which consists of 542 contigs with an N50 scaffold length of 3.21 Mb and 50.4% GC content. Meanwhile, 19,333 functional protein-coding genes, 338 tRNA and 111 rRNA were comprehensively predicted and highly annotated using various BLAST databases including non-redundant (Nr) protein sequence, nucleotide (Nt) sequence, Swiss-Prot, Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) and Clusters of Orthologous Groups (COG), as well as Pathogen Host Interactions (PHI) and Carbohydrate-Active enzymes (CAZy) databases. Antibiotics and Secondary Metabolites Analysis Shell (AntiSMASH) results showed that strain R1 has 37 SM biosynthetic gene clusters (BGCs), including 17 nonribosomal peptide synthetases (NRPSs), 13 polyketide synthetases (PKSs), 3 terpene synthases (Ts), 3 hybrid NRPS + PKS and 1 hybrid indole + NRPS. These findings improve our knowledge of the molecular biology of the genus Fusarium and would promote the discovery of new bioactive SMs from strain R1 using gene mining strategies including gene knockout and heteroexpression.Entities:
Keywords: Fusarium; antiSMASH; biosynthetic gene cluster; endophytic fungus; secondary metabolite; whole-genome sequence
Year: 2022 PMID: 35736454 PMCID: PMC9229708 DOI: 10.3390/metabo12060521
Source DB: PubMed Journal: Metabolites ISSN: 2218-1989
Figure 1Colony (a) and microscopic (b) morphology of strain R1.
Figure 2Genome diagram of strain R1.
Genomic assembly and functional annotation of strain R1 genome.
| Item | Value | Item | Count | Percentage (%) |
|---|---|---|---|---|
| Total length (bp) | 51,784,516 | All | 17,145 | 88.68 |
| Max length (bp) | 6,563,362 | NR | 16,803 | 86.91 |
| GC content (%) | 50.4 | NT | 15,461 | 79.97 |
| Gene number | 19,333 | Swiss-Prot | 11,026 | 57.03 |
| Gene total length (bp) | 24,687,144 | KEGG | 10,894 | 56.35 |
| Gene average length (bp) | 1276.94 | COG | 8048 | 41.63 |
| GC content in gene region (%) | 55.06 | GO | 8780 | 45.41 |
| Gene/Genome (%) | 47.67 | |||
| Contigs | 542 | |||
| N50 (bp) | 3,209,824 | |||
| N90 (bp) | 1,367,080 |
Figure 3Functional annotation of strain R1 genes encoding the proteins: (a) Orthologous Groups of proteins (COG) analysis; (b) Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis; (c) Gene Ontology (GO) analysis.
Figure 4Distribution map of mutation types in the pathogen PHI phenotype of strain R1.
Figure 5CAZy functional classification and the number of corresponding genes of strain R1.
Figure 6Comparison of BGC constituents in strain R1 with identified BGCs for biosynthesis of sansalvamide (a), NG-391 (b) and cyclosporin C (c).
Figure 7Thirteen secondary metabolites (a–m) previously discovered from strain R1.